SKYCLARYS Trademark

Trademark Overview

On Wednesday, September 28, 2022, a trademark application was filed for SKYCLARYS with the United States Patent and Trademark Office. The USPTO has given the SKYCLARYS trademark a serial number of 97611495. The federal status of this trademark filing is SU - REGISTRATION REVIEW COMPLETE as of Sunday, September 15, 2024. This trademark is owned by Reata Pharmaceuticals, Inc.. The SKYCLARYS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of Friedreich ataxia
skyclarys

General Information

Serial Number97611495
Word MarkSKYCLARYS
Filing DateWednesday, September 28, 2022
Status819 - SU - REGISTRATION REVIEW COMPLETE
Status DateSunday, September 15, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 15, 2023

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of Friedreich ataxia

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSunday, October 16, 2022
Primary Code005
First Use Anywhere DateWednesday, March 1, 2023
First Use In Commerce DateWednesday, March 1, 2023

Trademark Owner History

Party NameReata Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressIrving, TX 75063
Party NameReata Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIrving, TX 75063

Trademark Events

Event DateEvent Description
Saturday, October 1, 2022NEW APPLICATION ENTERED
Sunday, October 16, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, July 12, 2023ASSIGNED TO EXAMINER
Wednesday, July 12, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, August 15, 2023PUBLISHED FOR OPPOSITION
Tuesday, August 15, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, July 26, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, May 10, 2024PETITION TO REVIVE-GRANTED
Friday, May 10, 2024NOTICE OF REVIVAL - E-MAILED
Friday, May 10, 2024TEAS PETITION TO REVIVE RECEIVED
Friday, May 10, 2024SOU EXTENSION RECEIVED WITH TEAS PETITION
Tuesday, October 10, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, April 10, 2024SOU EXTENSION 1 FILED
Friday, May 10, 2024TEAS PETITION TO REVIVE RECEIVED
Tuesday, June 11, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, June 11, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, June 11, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, July 25, 2024SOU EXTENSION 1 GRANTED
Thursday, July 25, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 19, 2024USE AMENDMENT FILED
Monday, August 19, 2024TEAS STATEMENT OF USE RECEIVED
Thursday, August 22, 2024STATEMENT OF USE PROCESSING COMPLETE
Sunday, September 15, 2024ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Sunday, September 15, 2024NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, July 23, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL

Related Keywords

skyclarys ataxia friedreich treatment preparations pharmaceutical